Find a Commonwealth Resource
Exemestane
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Exemestane is a prescription medication available as 25 mg oral tablets, manufactured by Breckenridge Pharmaceutical, Inc. It belongs to the aromatase inhibitor class and is used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Exemestane
Access the FDA dataset for Exemestane — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025